GRAIL, Inc.
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- www.grail.com
The Galleri® Community Research Program
- Conditions
- Data Collection
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT06603259
- Locations
- 🇺🇸
GRAIL, Menlo Park, California, United States
Galleri in the Medicare Population
- Conditions
- Cancer
- Interventions
- Device: Multi-Cancer Early Detection Test (Galleri®)
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 50000
- Registration Number
- NCT05673018
- Locations
- 🇺🇸
Community Health Network, Indianapolis, Indiana, United States
Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial
- Conditions
- Cancer
- Interventions
- Device: Multi-cancer early detection test (Galleri test)
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 140000
- Registration Number
- NCT05611632
- Locations
- 🇬🇧
EMS Healthcare Ltd, Chester, United Kingdom
REFLECTION: A Clinical Practice Learning Program for Galleri®
- Conditions
- CancerEarly Detection of Cancer
- Interventions
- Other: MCEDOther: SOC
- First Posted Date
- 2022-01-25
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 17000
- Registration Number
- NCT05205967
- Locations
- 🇺🇸
WVU University Town Centre Family Medicine, Morgantown, West Virginia, United States
🇺🇸Vincere Cancer Center, Scottsdale, Arizona, United States
🇺🇸Providence, Mission, Mission Viejo, California, United States
PATHFINDER 2: a Multi-Cancer Early Detection Study
- Conditions
- CancerEarly Detection of Cancer
- Interventions
- Device: Multi-Cancer Early Detection Test
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 35885
- Registration Number
- NCT05155605
- Locations
- 🇺🇸
Sutter Health, Sacramento, California, United States
🇺🇸HOAG Irvine, Irvine, California, United States
🇺🇸HOAG Vivante Newport Mesa, Irvine, California, United States
Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice
- Conditions
- Cancer
- Interventions
- Device: Multi-Cancer Early Detection Test
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 6662
- Registration Number
- NCT04241796
- Locations
- 🇺🇸
Texas Oncology, PA (West TXO), Amarillo, Texas, United States
🇺🇸Woodlands Medical Specialists, PA, Pensacola, Florida, United States
🇺🇸Sutter Health, Roseville, California, United States
The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types
- Conditions
- CancerNeoplasms
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2022-10-17
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 99481
- Registration Number
- NCT03085888
- Locations
- 🇺🇸
Mayo Clinic, La Crosse, Wisconsin, United States
🇺🇸Sutter Health, Santa Rosa, California, United States
🇺🇸Scottsdale Medical Imaging Research, Scottsdale, Arizona, United States
The Circulating Cell-free Genome Atlas Study
- Conditions
- NeoplasmsCancer
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- GRAIL, Inc.
- Target Recruit Count
- 15254
- Registration Number
- NCT02889978
- Locations
- 🇺🇸
Southern Cancer Center, P.C. - Mobile Infirmary, Mobile, Alabama, United States
🇺🇸Southern Cancer Center, PC - Mobile Airport, Mobile, Alabama, United States
🇺🇸Mercy Fort Smith, Fort Smith, Arkansas, United States